Results 101 to 110 of about 147,087 (155)

COVID-19 IgG seropositivity and its determinants in occupational groups of varying infection risks in two Andean cities of Ecuador before mass vaccination. [PDF]

PLoS One
Leon-Rojas JE, Arias-Erazo F, Jiménez-Arias P, Recalde-Navarrete R, Guevara A, Coloma J, Martin M, Chis Ster I, Cooper P, Romero-Sandoval N, Seroprevalence ECU-Group.   +10 more
europepmc   +1 more source

Prevalence and factors associated with hepatitis b vaccination uptake and completion among communities targeted for mass vaccination in gulu: a cross-sectional study. [PDF]

BMC Public Health
Kimera A, Atuyambe L, Mutyaba H, Nantongo C, Namagembe A, Nalumansi AM, Basenero A, Auma P, Mukiza N, Mutyoba J.   +9 more
europepmc   +1 more source

Differentiating behavioral impact with or without vaccination certification under mass vaccination and non-pharmaceutical interventions on mitigating COVID-19. [PDF]

Sci Rep
Cao H, Cao L.
europepmc   +1 more source

An appraisal of the pros and cons of mass vaccination

Anales del Sistema Sanitario de Navarra, 2009
openaire   +3 more sources

[Meaningless mass vaccination].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2011
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adherence of mass vaccinators to timing guidelines for influenza vaccination

American Journal of Preventive Medicine, 2004
With recent delays in influenza vaccine availability, practitioners have been encouraged to time vaccination activities to promote vaccination of high-priority groups first. This cross-sectional survey of persons vaccinated in nontraditional settings (NTS) by mass vaccinators was conducted to assess how effectively the mass vaccinators were able to ...
Sarah J, D'Heilly, Jackie L, Lockman, Kristin L, Nichol   +2 more
openaire   +2 more sources

Mass Vaccination: Solutions in the Skin

2006
The skin is populated with Langerhans cells, thought to be efficient, potent antigen-presenting cells, that are capable of inducing protective immunity by targeting antigen delivery to the skin. Delivery to the skin may be accomplished by active delivery such as intradermal injection, use of patches or a combination of a universal adjuvant patch with ...
G M, Glenn, R T, Kenney
openaire   +2 more sources